Eli Lilly to boost its animal health division
By acquiring Ivy Animal Health Inc., a Kansas-based privately held pharmaceutical company, Eli Lilly and Co. plans to boost its animal health division.
After the acquisition, Ivy will be an operating unit of Elanco Animal Health
(a division of Eli Lilly). Last year, Elanco brought in $875.5 million in
revenue, a small portion of Lilly’s total of $15.7 billion.
Ivy’s
principal products are beef cattle growth promoting products. The company also
maintains a database on nutritional and health information for more than 60
million animals.
Ivy will continue to operate from its Overland Park,
Kan., location after the deal closes, according to Lilly.
Related
websites:
Elanco Animal Health
Eli Lilly
Ivy Animal Health
Inc.
Join 26,000+ subscribers
Subscribe to our newsletter to stay updated about all the need-to-know content in the feed sector, three times a week.
